Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.01 per share
-
Shares outstanding
-
46.2M
-
Number of holders
-
80
-
Total 13F shares, excl. options
-
14.5M
-
Shares change
-
-543K
-
Total reported value, excl. options
-
$261M
-
Value change
-
-$10.5M
-
Number of buys
-
33
-
Number of sells
-
-32
-
Price
-
$18.02
Significant Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q4 2020
92 filings reported holding URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share as of Q4 2020.
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.5M shares
of 46.2M outstanding shares and own 31.46% of the company stock.
Largest 10 shareholders include MENORA MIVTACHIM HOLDINGS LTD. (2.95M shares), WELLINGTON MANAGEMENT GROUP LLP (1.84M shares), BlackRock Inc. (1.53M shares), Wildcat Capital Management, LLC (1.25M shares), CREDIT SUISSE AG/ (1.12M shares), Phoenix Holdings Ltd. (820K shares), Migdal Insurance & Financial Holdings Ltd. (738K shares), Clal Insurance Enterprises Holdings Ltd (529K shares), STATE STREET CORP (440K shares), and Horton Capital Management, LLC (390K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.